H-Type Hypertension Is a Risk Factor for Cerebral Small-Vessel Disease

被引:45
作者
Li, Tan [1 ]
Liu, Xueyun [1 ]
Diao, Shanshan [1 ]
Kong, Yan [1 ]
Duan, Xiaoyu [1 ]
Yang, Si [1 ]
Liu, Sanjiao [1 ]
Fang, Qi [1 ]
Cai, Xiuying [1 ]
机构
[1] Soochow Univ, Affiliated Hosp 1, Dept Neurol, 899 Pinghai Rd, Suzhou 215006, Jiangsu, Peoples R China
关键词
ISCHEMIC-STROKE; HOMOCYSTEINE; ASSOCIATION; LEUKOARAIOSIS; SUBTYPE;
D O I
10.1155/2020/6498903
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Background. The correlation between H-type hypertension and cerebral small-vessel diseases (CSVD) remains uncertain. Objective. The present study was designed to explore the possible relationship between H-type hypertension and CSVD spectrum and total burden. Method. We included 329 patients in the present study and divided them into four groups: the H-type hypertension group, isolated hypertension group, isolated hyperhomocysteinemia (HHcy) group, and control group. Clinical variables of interest and the MR examination sequences were obtained. We counted the presence of each CSVD feature and rated the total burden of CSVD on an ordinal scale from 0 to 4 according to a recent described score rule. Result. The results showed that H-type hypertension was associated with the presence of cerebral microbleeds (CMBs), and the severity of white-matter hyperintensities (WMHs) and peripheral vascular space (PVS). CSVD total burden was significantly related to age (OR: 1.059, 95% CI: 1.037-1.082), systolic pressure (OR: 1.122, 95% CI: 1.007-1.136), triglycerides (OR: 1.386, 95% CI: 1.037-1.854), isolated HHcy (OR: 4.154, 95% CI 1.836-9.401), and H-type hypertension (OR: 5.028, 95% CI: 2.323-10.883). Also, we further observed hypertension and HHcy had a synergistic effect on CSVD total burden (OR: 2.776, 95% CI: 1.564-4.927). Conclusion. H-type hypertension was associated with CSVD total burden and CSVD spectrum, which deserves further prevention measures. Furthermore, hypertension and HHcy had a synergistic effect on CSVD total burden.
引用
收藏
页数:6
相关论文
共 31 条
[1]   Homocysteine and coronary atherosclerosis: from folate fortification to the recent clinical trials [J].
Antoniades, Charalambos ;
Antonopoulos, Alexios S. ;
Tousoulis, Dimitris ;
Marinou, Kyriakoula ;
Stefanadis, Christodoulos .
EUROPEAN HEART JOURNAL, 2009, 30 (01) :6-15
[2]   Small vessel disease and clinical outcomes after IV rt-PA treatment [J].
Arba, F. ;
Inzitari, D. ;
Ali, M. ;
Warach, S. J. ;
Luby, M. ;
Lees, K. R. .
ACTA NEUROLOGICA SCANDINAVICA, 2017, 136 (01) :72-77
[3]   The renin-angiotensin-aldosterone system in cerebral small vessel disease [J].
Brenner, David ;
Labreuche, Julien ;
Pico, Fernando ;
Scheltens, Philip ;
Poirier, Odette ;
Cambien, Francois ;
Amarenco, Pierre .
JOURNAL OF NEUROLOGY, 2008, 255 (07) :993-1000
[4]  
Chen SY, 2006, DYNAM CONT DIS SER B, V13E, P261
[5]   Acute methionine load-induced hyperhomocysteinemia enhances platelet aggregation thromboxane biosynthesis, and macrophage-derived tissue factor activity in rats [J].
Durand, P ;
LussierCacan, S ;
Blache, D .
FASEB JOURNAL, 1997, 11 (13) :1157-1168
[6]   MR SIGNAL ABNORMALITIES AT 1.5-T IN ALZHEIMER DEMENTIA AND NORMAL AGING [J].
FAZEKAS, F ;
CHAWLUK, JB ;
ALAVI, A ;
HURTIG, HI ;
ZIMMERMAN, RA .
AMERICAN JOURNAL OF ROENTGENOLOGY, 1987, 149 (02) :351-356
[7]   Role of homocysteine in the development of cardiovascular disease [J].
Ganguly, Paul ;
Alam, Sreyoshi Fatima .
NUTRITION JOURNAL, 2015, 14
[8]   Plasma homocysteine as a risk factor for vascular disease - The European concerted action project [J].
Graham, IM ;
Daly, LE ;
Refsum, HM ;
Robinson, K ;
Brattstrom, LE ;
Ueland, PM ;
PalmaReis, RJ ;
Boers, GHJ ;
Sheahan, RG ;
Israelsson, B ;
Uiterwaal, CS ;
Meleady, R ;
McMaster, D ;
Verhoef, P ;
Witteman, J ;
Rubba, P ;
Bellet, H ;
Wautrecht, JC ;
deValk, HW ;
Luis, ACS ;
ParrotRoulaud, FM ;
Tan, KS ;
Higgins, I ;
Garcon, D ;
Medrano, MJ ;
Candito, M ;
Evans, AE ;
Andria, G .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1997, 277 (22) :1775-1781
[9]   Comparison of oxidative stress biomarkers in hypertensive patients with or without hyperhomocysteinemia [J].
Guo, Gang ;
Sun, Wenjiang ;
Liu, Guanghui ;
Zheng, Huan ;
Zhao, Jiasheng .
CLINICAL AND EXPERIMENTAL HYPERTENSION, 2018, 40 (03) :262-266
[10]   Homocysteine is a risk factor for cerebral small vessel disease, acting via endothelial dysfunction [J].
Hassan, A ;
Hunt, BJ ;
O'Sullivan, M ;
Bell, R ;
D'Souza, R ;
Jeffery, S ;
Bamford, JM ;
Markus, HS .
BRAIN, 2004, 127 :212-219